PRAKASH MASAND to Antidepressive Agents
This is a "connection" page, showing publications PRAKASH MASAND has written about Antidepressive Agents.
Connection Strength
1.752
-
Beyond serotonin: newer antidepressants in the future. Expert Rev Neurother. 2017 08; 17(8):777-790.
Score: 0.479
-
Quetiapine augmentation for depression: dosing pattern in routine practice. Int Clin Psychopharmacol. 2015 Jan; 30(1):54-8.
Score: 0.404
-
Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting. Int Clin Psychopharmacol. 2014 Mar; 29(2):116-9.
Score: 0.381
-
Tolerability and adherence issues in antidepressant therapy. Clin Ther. 2003 Aug; 25(8):2289-304.
Score: 0.183
-
Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the Clinician. J Clin Psychopharmacol. 2019 Nov/Dec; 39(6):665-672.
Score: 0.141
-
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. Clin Neuropharmacol. 2009 Mar-Apr; 32(2):85-8.
Score: 0.067
-
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol. 2006 Dec; 26(6):653-6.
Score: 0.058
-
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. J Affect Disord. 2020 11 01; 276:576-584.
Score: 0.037